ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Tesla acquires AI hardware company for up to $2 billion in stock
- Bel Fuse acquires dataMate ethernet business for $16 million
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
ResMed (RMD) Tops Q4 EPS by 1c, Revenues Beat
July 25, 2019 4:27 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.95, $0.01 better than the analyst estimate of $0.94. Revenue for the quarter came in at $705 million versus the consensus estimate of $702.28 million.
Fourth Quarter 2019 Highlights
Revenue increased 13% to $705.0 million; up 15% on a constant currency basisGross margin expanded 120 bps... More
